Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease
Avastin Increases Overall Survival 3.7 Months
First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma
Phase III Trial of ThermoDox Fails to Meet Primary Endpoint
Neulasta Reduces Incidence Of Febrile Neutropenia
Tivozanib Does Not Improve OS Compared to Sorafenib
In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up
Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade
Protein May Link Obesity To Cancer Aggressiveness
“Triple-Negative” Should Be Split Into Subtypes, Say Researchers
NCI CTEP Approved Trials For the Month of February
Avastin Combination Approved For Metastatic Colorectal Cancer
FDA Grants Priority Review To Two Drugs in NSCLC
Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- The Mark Foundation names 2026 Emerging Leader Award recipients
- When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care - Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”
- Minimally invasive surgery lowers survival in cervical cancer, new studies show
- A radiation oncologist’s perspective: Why we need to accelerate early detection strategies for lung cancers
